Characterization of chromosome 5 aberrations in TP53 mutated myeloid neoplasms with ≥5% blasts: An International TP53 Investigators Network (iTiN) study.
Saved in:
| Title: | Characterization of chromosome 5 aberrations in TP53 mutated myeloid neoplasms with ≥5% blasts: An International TP53 Investigators Network (iTiN) study. |
|---|---|
| Authors: | Yasin I; Pathology (Hematology/Oncology & Hematopathology & Genomic Pathology & Cytogenetics), Medicine (Hematology/Oncology), The University of Chicago Medicine, Chicago, Illinois, USA., Stengel A; Munich Leukemia Laboratory, Munich, Germany., Shao H; Pathology (Hematopathology), Medicine (Hematology Oncology), H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA., Kaur A; Pathology (Molecular Pathology), Endeavor Health Northshore Hospital, Evanston, Illinois, USA., Mason EF; Pathology, Microbiology, and Immunology (Hematopathology), Vanderbilt University Medical Center, Nashville, Tennessee, USA., Patwardhan PP; Pathology (Hematopathology), University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA., Bailey NG; Pathology (Hematopathology), Mayo Clinic, Rochester, Minnesota, USA., Ghosh S; Pathology (Hematopathology), Henry Ford Health System, Detroit, Michigan, USA., Inamdar KV; Pathology (Hematopathology), Henry Ford Health System, Detroit, Michigan, USA., Patel AA; Pathology (Hematology/Oncology & Hematopathology & Genomic Pathology & Cytogenetics), Medicine (Hematology/Oncology), The University of Chicago Medicine, Chicago, Illinois, USA., Pandiri M; Pathology (Hematology/Oncology & Hematopathology & Genomic Pathology & Cytogenetics), Medicine (Hematology/Oncology), The University of Chicago Medicine, Chicago, Illinois, USA., Zhang J; Pathology (Hematopathology & Children's Hospital of Colorado), UCHealth University of Colorado Hospital, Anschutz Medical Campus, Aurora, Colorado, USA., Sojitra P; Pathology, Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey, USA., Tariq H; Pathology (Hematopathology), Northwestern Memorial Hospital, Chicago, Illinois, USA., Pan Z; Pathology (Hematopathology & Children's Hospital of Colorado), UCHealth University of Colorado Hospital, Anschutz Medical Campus, Aurora, Colorado, USA., Wiredja D; Pathology (Hematopathology & Children's Hospital of Colorado), UCHealth University of Colorado Hospital, Anschutz Medical Campus, Aurora, Colorado, USA., Wang P; Pathology (Hematology/Oncology & Hematopathology & Genomic Pathology & Cytogenetics), Medicine (Hematology/Oncology), The University of Chicago Medicine, Chicago, Illinois, USA., Tjota MY; Pathology (Hematology/Oncology & Hematopathology & Genomic Pathology & Cytogenetics), Medicine (Hematology/Oncology), The University of Chicago Medicine, Chicago, Illinois, USA., Segal JP; Pathology (Hematology/Oncology & Hematopathology & Genomic Pathology & Cytogenetics), Medicine (Hematology/Oncology), The University of Chicago Medicine, Chicago, Illinois, USA., Chang H; Laboratory Medicine Program (Laboratory Hematology), University of Toronto, Toronto, Ontario, Canada., Sallman DA; Pathology (Hematopathology), Medicine (Hematology Oncology), H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA., Arber DA; Pathology (Hematology/Oncology & Hematopathology & Genomic Pathology & Cytogenetics), Medicine (Hematology/Oncology), The University of Chicago Medicine, Chicago, Illinois, USA., Tefferi A; Medicine (Division of Hematology), Mayo Clinic, Rochester, Minnesota, USA., Badar T; Medicine (Hematology- Oncology), Mayo Clinic, Jacksonville, Florida, USA., Perry AM; Pathology (Hematopathology), University of Michigan, Ann Arbor, Minnesota, USA., Haferlach C; Munich Leukemia Laboratory, Munich, Germany., Lager AM; Pathology (Hematology/Oncology & Hematopathology & Genomic Pathology & Cytogenetics), Medicine (Hematology/Oncology), The University of Chicago Medicine, Chicago, Illinois, USA., Venkataraman G; Pathology (Hematology/Oncology & Hematopathology & Genomic Pathology & Cytogenetics), Medicine (Hematology/Oncology), The University of Chicago Medicine, Chicago, Illinois, USA. |
| Source: | Cancer [Cancer] 2026 Jan 01; Vol. 132 (1), pp. e70210. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Wiley Country of Publication: United States NLM ID: 0374236 Publication Model: Print Cited Medium: Internet ISSN: 1097-0142 (Electronic) Linking ISSN: 0008543X NLM ISO Abbreviation: Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
